Serum biomarkers as potential predictors of antitumor activity of cetuximab-containing therapy for locally advanced head and neck cancer
about
De-escalation treatment protocols for human papillomavirus-associated oropharyngeal squamous cell carcinomaDiet and proinflammatory cytokine levels in head and neck squamous cell carcinoma.Phase II study of cetuximab in combination with cisplatin and radiation in unresectable, locally advanced head and neck squamous cell carcinoma: Eastern cooperative oncology group trial E3303.Infectious complications in head and neck cancer patients treated with cetuximab: propensity score and instrumental variable analysisCA-SSR1 Polymorphism in Intron 1 of the EGFR Gene in Patients with Malignant Tumors Who Develop Acneiform Rash Associated with the Use of Cetuximab.PRAME expression in head and neck cancer correlates with markers of poor prognosis and might help in selecting candidates for retinoid chemoprevention in pre-malignant lesions.STAT3 regulates arginase-I in myeloid-derived suppressor cells from cancer patients.Gene expression changes in melanoma metastases in response to high-dose chemotherapy during isolated limb perfusion.Performance assessment of a Trypanosoma cruzi chimeric antigen in multiplex liquid microarray assays.Effect of selective small molecule inhibitors on MMP-9 and VEGFR-1 expression in p16-positive and -negative squamous cell carcinoma.PRAME induces apoptosis and inhibits proliferation of leukemic cells in vitro and in vivo.Genetic ablation of epidermal EGFR reveals the dynamic origin of adverse effects of anti-EGFR therapy.Interleukin-6 role in head and neck squamous cell carcinoma progression.Plasma proteins as prognostic biomarkers in radiotherapy treated head and neck cancer patients.Predictors of circulating INTERLEUKIN-6 levels in head and neck cancer patients.IFN-γ and other serum cytokines in head and neck squamous cell carcinomas.Simultaneous evaluation of anti-EGFR-induced tumour and adverse skin effects in a microfluidic human 3D co-culture model
P2860
Q24200362-BDF86E17-9D19-48C1-92F6-F3A8C0BB6954Q34076276-28675528-0FAC-4376-82C5-54852C34BB46Q34287666-1D95ED1C-4DB4-44ED-AEDB-FE77787B00E5Q34499968-B72337D6-4742-4EAD-A7F8-A2460C933CE8Q36012730-50258AE0-7A7B-4E1B-BA23-A13DCF6FC408Q36714088-E4258EA4-9EBE-4D3E-9C85-594614231677Q36733391-915366ED-F8CD-43F2-A2D7-D059175499ADQ39367548-748AD76E-F8BD-4504-A9D4-DCC923623F5CQ39429886-ADD65099-C08B-4956-A0A7-9C1305B959A2Q40196342-67B10222-55EE-412B-ACC5-59BD00989386Q43087749-B05D933A-1137-4649-9068-5EFE3F42E03EQ43521257-EDC8A70F-ED61-44B8-B235-53521E1BA804Q55031288-4FCC8ECA-1E01-4609-B465-AC6C67D5CF6BQ55280852-29A17A37-07E8-4683-946F-4AFDBCA61591Q55312802-8E87BE2C-A371-45BA-91C5-5F73761C9EFBQ55409100-8E153034-28A8-4439-A147-DB41A7DE9914Q57292420-19FA1934-F476-4726-8553-08980853050C
P2860
Serum biomarkers as potential predictors of antitumor activity of cetuximab-containing therapy for locally advanced head and neck cancer
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Serum biomarkers as potential ...... advanced head and neck cancer
@ast
Serum biomarkers as potential ...... advanced head and neck cancer
@en
type
label
Serum biomarkers as potential ...... advanced head and neck cancer
@ast
Serum biomarkers as potential ...... advanced head and neck cancer
@en
prefLabel
Serum biomarkers as potential ...... advanced head and neck cancer
@ast
Serum biomarkers as potential ...... advanced head and neck cancer
@en
P2093
P2860
P50
P1433
P1476
Serum biomarkers as potential ...... advanced head and neck cancer
@en
P2093
Athanassios Argiris
Raja Seethala
Steve C Lee
Trevor Feinstein
William Gooding
P2860
P304
P356
10.1016/J.ORALONCOLOGY.2011.07.034
P407
P577
2011-09-01T00:00:00Z